Home › Funds › APIS CAPITAL ADVISORS, LLC › TVTX
APIS CAPITAL ADVISORS, LLC position in TVTX
TRAVERE THERAPEUTICS INC · Health Care
APIS CAPITAL ADVISORS, LLC reported holding 158,000 shares of TVTX (TRAVERE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$9.3M, representing 1.31% of its reported portfolio and ranking #27 among its reported holdings. APIS CAPITAL ADVISORS, LLC has disclosed TVTX holdings in 4 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How APIS CAPITAL ADVISORS, LLC's TVTX position evolved
APIS CAPITAL ADVISORS, LLC first disclosed a stake in TVTX in Q3 2025 at 166,000 shares (US$4.0M). The position peaked in Q3 2026 at 158,000 shares, worth US$9.3M. Across 4 filings, APIS CAPITAL ADVISORS, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 158,000 shares valued at US$9.3M — an increase of 46,000 shares quarter over quarter.. Notable position changes include a 41% increase in Q3 2026 (shares fell 14% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 166.00K | $3.97M | New |
| Q4 2025 | 186.00K | $7.11M | Add |
| Q2 2026 | 112.00K | $6.36M | New |
| Q3 2026 | 158.00K | $9.30M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TVTX and 13F data
TVTX (TRAVERE THERAPEUTICS INC) is a Health Care company. 57 other funds we track also report a position in TVTX — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$213.2M), Rock Springs Capital Management LP (US$123.8M), Kynam Capital Management, LP (US$113.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TVTX
- PERCEPTIVE ADVISORS LLC 3.75M sh · $213.18M · Q2 2026
- Rock Springs Capital Management LP 2.18M sh · $123.79M · Q2 2026
- Kynam Capital Management, LP 2.00M sh · $113.62M · Q2 2026
- Stephens Investment Management Group LLC 1.88M sh · $110.50M · Q3 2026
- EMERALD ADVISERS, LLC 1.56M sh · $92.06M · Q3 2026
- Context Capital Management, LLC 62.70M sh · $73.14M · Q3 2026
- MPM BioImpact LLC 1.12M sh · $63.78M · Q2 2026
- EMERALD MUTUAL FUND ADVISERS TRUST 984.85K sh · $57.99M · Q3 2026
- Jones Hill Capital LP 959.63K sh · $56.50M · Q3 2026
- Eversept Partners, LP 798.97K sh · $45.39M · Q2 2026
- Polar Asset Management Partners Inc. 30.50M sh · $35.91M · Q2 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 28.00M sh · $32.96M · Q2 2026
More on APIS CAPITAL ADVISORS, LLC
FAQ
How long has APIS CAPITAL ADVISORS, LLC held TVTX?
APIS CAPITAL ADVISORS, LLC has disclosed TVTX holdings in 4 of the last 5 reported quarters, going back to Q3 2025.
What is APIS CAPITAL ADVISORS, LLC's current position in TVTX?
As of Q3 2026, APIS CAPITAL ADVISORS, LLC holds 158.00K shares of TVTX (TRAVERE THERAPEUTICS INC), valued at $9.30M, representing 1.31% of its reported portfolio and ranking #27.
Has APIS CAPITAL ADVISORS, LLC been buying or selling TVTX?
In the latest 13F filing (Q3 2026), APIS CAPITAL ADVISORS, LLC increased its position in TVTX. The position peaked in Q3 2026 at 158.00K shares.
Which other funds hold TVTX?
Other major institutional holders of TVTX include PERCEPTIVE ADVISORS LLC, Rock Springs Capital Management LP, Kynam Capital Management, LP, among 57 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.